BRIEF published on 05/13/2025 at 07:05, 11 months 29 days ago Innate Pharma Reports First Quarter 2025 Results Financial Results Clinical Trials Innate Pharma Sanofi Investment Lacutamab FDA
PRESS RELEASE published on 05/13/2025 at 07:00, 11 months 29 days ago Informations privilégiées / Communiqué sur comptes, résultats Innate Pharma annonce ses résultats financiers du premier trimestre 2025 et les avancées de son portefeuille, incluant des investissements et des études cliniques. Une conférence téléphonique est prévue à 14h00 CEST Résultats Financiers Conférence Téléphonique Portefeuille Études Cliniques Innate Pharma
PRESS RELEASE published on 05/13/2025 at 07:00, 11 months 29 days ago Inside Information / News release on accounts, results Innate Pharma reports Q1 2025 business update with €15 million investment by Sanofi, FDA Breakthrough Therapy Designation for lacutamab, and cash position of €72.5 million FDA Financial Results Sanofi Innate Pharma Q1 2025
BRIEF published on 05/02/2025 at 15:27, 1 year ago Sanofi augmente sa participation dans Innate Pharma Capital Actions Franchissement De Seuils Sanofi Innate Pharma
BRIEF published on 05/02/2025 at 15:27, 1 year ago Sanofi increases its stake in Innate Pharma Capital Actions Crossing Thresholds Sanofi Innate Pharma
PRESS RELEASE published on 05/02/2025 at 15:22, 1 year ago Franchissement de seuils Déclaration de franchissement de seuils par Sanofi pour Innate Pharma via augmentation de capital Augmentation De Capital Franchissement De Seuils Sanofi Innate Pharma
BRIEF published on 04/29/2025 at 21:05, 1 year ago Innate Pharma Presents Promising Preclinical Data for IPH4502 at AACR 2025 Preclinical Data Innate Pharma IPH4502 Nectin-4 Antibody Drug Conjugate
BRIEF published on 04/29/2025 at 21:05, 1 year ago Innate Pharma présente des données précliniques prometteuses pour IPH4502 à l'AACR 2025 Innate Pharma Données Précliniques Conjugué Anticorps-médicament IPH4502 Nectine-4
PRESS RELEASE published on 04/29/2025 at 21:00, 1 year ago Inside Information / Other news releases Innate Pharma presents preclinical data for IPH4502, a Nectin-4 targeting ADC, showing superior anti-tumor efficacy in multiple cancer models at AACR 2025 Annual Meeting Preclinical Data Innate Pharma IPH4502 AACR 2025 Nectin-4 ADC
PRESS RELEASE published on 04/29/2025 at 21:00, 1 year ago Informations privilégiées / Autres communiqués Innate Pharma présente les données précliniques prometteuses d'IPH4502, un conjugué anticorps-médicament innovant ciblant Nectine-4, au congrès annuel de l'AACR 2025 Préclinique Innate Pharma Conjugué Anticorps-médicament IPH4502 AACR 2025
Published on 05/11/2026 at 14:30, 4 hours 35 minutes ago Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
Published on 05/11/2026 at 14:00, 5 hours 5 minutes ago Unusual Machines Accelerates Domestic Battery Manufacturing by Signing a Merger Agreement to Acquire Upgrade Energy
Published on 05/11/2026 at 14:00, 5 hours 5 minutes ago New Horizon Aircraft Ltd. Announces Closing of $20 Million Offering of Common Shares
Published on 05/11/2026 at 14:00, 5 hours 5 minutes ago Colosseum Bankable Feasibility Study Confirms High Margin Gold Project
Published on 05/11/2026 at 14:00, 5 hours 5 minutes ago Ur-Energy Reminds Shareholders and Interested Parties of First Quarter Conference Call and Webcast
Published on 05/11/2026 at 18:30, 35 minutes ago VAZIVA SA: Report de la publication du rapport financier annuel 2025
Published on 05/11/2026 at 18:25, 40 minutes ago SAP and Cyberwave Deploy Fully Autonomous AI-Powered Robots in Live SAP Logistics Warehouse
Published on 05/11/2026 at 18:00, 1 hour 5 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 11 05 2026
Published on 05/11/2026 at 18:00, 1 hour 5 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 05/11/2026 (French only)
Published on 05/11/2026 at 18:00, 1 hour 5 minutes ago Forbo accelerates Movement Systems transformation: new operating model and direct CEO leadership
Published on 05/11/2026 at 18:18, 47 minutes ago Reporting on share buyback transactions carried out between May 4 and May 5, 2026
Published on 05/11/2026 at 18:18, 47 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 4 et 5 mai 2026
Published on 05/11/2026 at 18:14, 50 minutes ago Nombre total d'actions et droits de vote - avril 2026
Published on 05/11/2026 at 18:14, 50 minutes ago Number of shares and voting rights - April 2026 (In French only)
Published on 05/11/2026 at 18:00, 1 hour 5 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 avril 2026
